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Abstract
Background: Several studies have showed that people with intellectual disabilities (ID) have suitable skills to
undergo cognitive behavioural therapy (CBT). Case studies have reported successful use of cognitive behavioural
therapy techniques (with adaptations) in people with ID. Modified cognitive behavioural therapy may be a feasible
and effective approach for the treatment of depression, anxiety, and other mood disorders in ID. To date, two
studies have reported group-based manaulised cognitive behavioural treatment programs for depression in people
with mild ID. However, there is no individual manualised programme for anxiety or depression in people with
intellectual disabilities. The aims of the study are to determine the feasibility of conducting a randomised
controlled trial for CBT in people with ID. The data will inform the power calculation and other aspects of carrying
out a definitive randomised controlled trial.
Methods: Thirty participants with mild ID will be allocated randomly to either CBT or treatment as usual (TAU). The
CBT group will receive up to 20 hourly individual CBT over a period of 4 months. TAU is the standard treatment
which is available to any adult with an intellectual disability who is referred to the intellectual disability service
(including care management, community support, medical, nursing or social support). Beck Youth Inventories (Beck
Anxiety Inventory & Beck Depression Inventory) will be administered at baseline; end of treatment (4 months) and
at six months to evaluate the changes in depression and anxiety. Client satisfaction, quality of life and the health
economics will be secondary outcomes.
Discussion: The broad outcome of the study will be to produce clear guidance for therapists to apply an
established psychological intervention and identify how and whether it works with people with intellectual
disabilities.
Trial registration: ISRCTN: ISRCTN38099525
Background
The level of psychopathology in people with intellectual
disabilities (ID) is higher than in the general population
[1] with depression, anxiety and mixed affective disorder
being the commonest diagnoses. The prevalence rates
for affective disorder and anxiety in a random commu-
nity sample of 90 adults with ID using a structured
assessment and International Classification of Diseases
(ICD-10) criteria were 8.8% and 14.4% respectively [2].
Two recent studies which compared birth cohorts of
adults with and without ID found a four [3] to six fold
[4] increase in common affective disorders in adults
with mild ID.
It has been suggested that psychotherapy in general is
not effective in people with ID [5-9]. This is possibly
due to long-held assumptions that people with ID have
insufficient intellectual capacity to use talking therapies
as well as a lack of instruments to measure change in
symptoms, “therapeutic disdain” [10], a reluctance to
work collaboratively and to understand the mental
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world of the patient [11]. However, in recent years,
there has been a greater focus on the psychological
needs of people with ID, and therapeutic optimism
borne out of greater understanding of the adaptations
required to improve interventions for this group. Recent
limited evidence suggests that at least a year’s psychody-
namic orientated therapy with adults across the range of
intellectual disability leads to positive outcomes in
improving emotional intelligence [12].
Evidence from work with children suggests that a
mature cognitive function may not be necessary for an
individual to make use of cognitive behaviour therapy
(CBT) [13]. Indeed some research has found that people
with mild to moderate intellectual disability are able to
establish links between thoughts and feelings, an impor-
tant rationale underpinning CBT [14].
Successful use of CBT has been reported in case stu-
dies of adults with mild intellectual disability who
offended exhibited problem behaviours [15], anxiety [16]
or suffered with long term psychotic symptoms [17]. A
meta-analysis of the efficacy of psychotherapy in adults
with intellectual disability [18] found that cognitive
behavioural methods were used in 13% of all the studies
reviewed. The outcome of this meta-analysis suggested
an effect size for CBT of 3.08. However most CBT inter-
ventions have focused on the behavioural rather than
cognitive aspects of the interventions [19,20] looking at
observable behaviour rather than psychological change
as the outcome measure.
There are many challenges to conducting well
designed randomised trials (RCTs) in this field, includ-
ing ethical objections, the need to involve carers and
lack of resources for the intervention [21]. Only two
RCTs have been published using CBT in ID and these
addressed anger management in secure units [22] and in
a community setting [15] using self management and
cognitive techniques [23-25].
Cognitive behaviour techniques in people with ID are
often adapted to include use of pictures, role plays and
simpler questioning styles. Therapy may need to pro-
ceed at a slower pace with therapy sessions shorter than
the usual 50 minutes [26]. We are not aware of any gen-
eral treatment manuals for CBT in adults with ID
despite increasing demand for training.
In summary, the evidence for efficacy of CBT in people
with mild ID is weak and based on small case studies or
clinical trials that have significant methodological short-
comings [27]. In addition, positive outcome maybe asso-
ciated with spontaneous remission in symptoms of
depression and/or anxiety [28,28]. Reliable and valid out-
come measures are rarely used [18], and the treatments
are not standardised (see Journal of Applied Research in
Intellectual Disabilities special issue, 2006).
The rationales for proposing this study are:
• A poor evidence base for efficacy of psychological
treatments in people with ID;
• Exclusion from access to established health inter-
ventions for common mental disorders of this popu-
lation [30];
• Little understanding of how and why treatments
established in other populations might be effective in
adults with ID.
This is a preliminary study in order to adapt and
operationalise a standard intervention for a specific ser-
vice user group. The broad outcome of the study will be
to produce clear guidance for CBT trained therapists to
apply the intervention and identify how and whether it
works in this group.
Hypothesis
Cognitive behaviour treatment is more clinically and
cost effective than treatment as usual for depression,
anxiety and mixed affective states in adults with mild
intellectual disabilities.
Objectives
The aims of the present trial are:
• To develop a manual outlining how to carry out
cognitive behavioural treatment for common mental
disorders in adults with mild ID.
• To determine the feasibility of conducting a rando-
mised controlled trial of individual CBT versus treat-
ment as usual (TAU) for the treatment of depression
and anxiety in adults with mild ID.
• To use data arising on differences between CBT
and TAU to inform a power calculation for numbers
in a definitive randomised controlled trial.
• To identify the clinically useful elements in the
treatment manual.
• To investigate satisfaction with the intervention
and service costs.
Methods/Design
Study Design
Potential participants’ referrals will be taken from pro-
fessionals across two local intellectual disability services
in the London boroughs of Camden and Islington in the
United Kingdom, as well as new referrals that fulfill
inclusion criteria. Participants will be randomly allocated
to Cognitive Behavioural Therapy plus treatment as
usual (CBT) or Treatment as Usual (TAU). Figure 1
shows the trial design.
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Screening and participant recruitment
A total of thirty (n = 30) participants will be recruited
for the study. Potential participants will be screened for
the trial using the depression and anxiety components
of the Mini Psychiatric Assessment Schedules for Adults
with Developmental Disabilities (Mini PAS-ADD) [31].
Those with scores of more than 10 for depression and
more than 7 for anxiety will be eligible and randomized
into the study. The range of scores indicating severity is
between 11 and 32 for depression and 7-18 for anxiety.
1
Figure 1: CBT Study Flow Diagram 
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Figure 1 CBT Study Flow Diagram.
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Inclusion criteria:
• Participants will be adults (over 18 years of age)
who have mild intellectual disability (as determined
on the service register).
• Have a disorder according to one of the following
International Classification of Diseases-10 (ICD-10)
[32] codes: F 32, 33, 34, 34, 38, 40, 41 (anxiety,
depression or mixed affective states).
• Each participant will also require an informant,
who has known them for at least six months, and
who will also be available throughout the study to
complete assessments.
Exclusion criteria:
• Participants with co-morbid conditions of sub-
stance misuse, autism and those currently receiving
psychological treatment.
• Service users with moderate/severe ID.
Randomisation
The randomization procedure (randomized permuted
blocks) will be supervised by Robert Blizard, statistician, and
administered by a departmental secretary (allocation conceal-
ment). The research assistant who will carry out the clinical
and cost assessments (at baseline, end of treatment and fol-
low-up) will remain blind to the treatment allocation of the
participants until they have reached the end of the study.
Intervention: Manualised Individual Cognitive Behavioural
Therapy (CBT)
The participants will receive up to 16 weekly one-to-one
treatment sessions of 60 minutes each offered over a
period of 4 months. The CBT will be delivered by quali-
fied CBT. The CBT manual will be developed in the
first phase of the study by the research team comprising
of specialists in the fields of intellectual disabilities, CBT
and health interventions as well as clinical psychologists
and speech and language therapists who have worked
with people with intellectual disabilities.
A support worker also will be employed for the trial
to help the participants through the treatment. His/her
duties will involve facilitating appointments for those
receiving CBT session and assist homework tasks.
The CBT therapists delivering the intervention will be
supervised by the Consultant CBT Therapists (MS) and
the support worker will be supervised by the Consultant
Psychiatrist (AH).
Control Group
Treatment As Usual (TAU) is defined as the standard
treatment that would be available to any adult with an
intellectual disability who has been referred to the intellec-
tual disability service. This includes care management,
medical, nursing, psychological input and/or social support.
Primary outcomes
Beck Anxiety and Depression Inventory Youth (BAI-Y &
BDI-Y): Two subscales from the Beck Youth Inventories
(BYI) [33] will be used to measure the severity of the
cognitive accepts of depression and/or anxiety. This is a
self-report assessment where each subscale consists of
21-items that are rated along a four- point Likert scale
(’never’, ‘sometimes’, ‘often’ or ‘always’). The participant
is required to rate each item in the scale that best repre-
sents their current mood especially during the last two
weeks. Both subscales will be administered at baseline,
end of treatment (four months) and at a six months fol-
low-up. We have chosen the Youth Inventories because
they are particularly sensitive to cognitive change and
brief and simple in their language which will only
require minimal change (for example the word “school”
will be replaced by “college” or “work”). This point is of
special importance in people with ID who may have dif-
ficulty in self reporting thoughts and emotional states. A
questionnaire that is couched in accessible terms is
invaluable in assisting people with mild ID to communi-
cate their emotional and social distress. In addition, the
service users will be offered assistance to clarify terms
by the researcher if necessary. Furthermore, research
has shown that the Beck Inventories can reliably and
consistently be used with people with mild ID [34].
Secondary Outcomes
Client satisfaction questionnaire (CSQ-8) [35]: Satisfac-
tion with treatment will be measured by using a modi-
fied client satisfaction self-assessment questionnaire that
consists of eight statements of satisfaction eliciting the
client’s perception of the mental health service/interven-
tion rated on a four point Likert scale at 4 months from
baseline (i.e. end of treatment).
Manchester Short Assessment of Quality of Life
(MANSA) [36]: This is a quality of life questionnaire
that consists of 16-items derived from the Lancashire
Quality of Life Profile [37]. MANSA comprises 4 objec-
tive questions and 12 subjective questions. The subjec-
tive items assess satisfaction with life as a whole,
employment status, financial situation, number and
quality of friendships, leisure activities, accommodation,
personal safety, living arrangement ( living with others
or alone), sex life, relationship with family, physical
health and mental health. Each item is rated on a seven-
point satisfaction scale, from 1 = ‘Couldn’t be worse’ to
7 = ‘Couldn’t be better’. This questionnaire will be
administered at baseline and at 4 months (i.e. end of
treatment).
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Client Service Receipt Inventory (CSRI) [38]: this is a
validated tool used to evaluate the cost and use of
health resources and services by service users with psy-
chiatric problems and learning disabilities [39,40]. The
questionnaire will be tailored to suit the data require-
ments and broad approach to data collection for this
trial. We will record information such as the use (fre-
quency and duration) of health and social care services,
hospital attendance and admissions, accommodation
and living situations, educational services, income,
employment and benefits. Data will be collected directly
from the service user, support workers’ and from the
service records to determine service use. Costs will be
measured at baseline and at 4 months (i.e. end of
treatment).
Qualitative interviews
We will also carry out fifteen minutes interviews’ con-
sisting of open ended questions with prompts that will
focus on obtaining the participant and their carer or
support worker’s experiences and the process of therapy.
These will be administered once the intervention has
been completed. The interviews will be analysed using
NVivo software for themes, commonalities and differ-
ences in opinions.
Treatment Manual
The final version of the manual will be informed by the
practical use of the manual and the therapists’ feedback.
A professional writer will assist with producing a high
quality document to allow for an accessible and enga-
ging manual that can be utilised effectively.
Treatment process evaluation
It has been suggested that there are three factors that
are important for successful psychotherapeutic interven-
tions: treatment delivery, receipt and enactment [41].
Treatment delivery aims to determine whether the pro-
posed treatment is actually being given by the therapist.
Modified CBT will be delivered by a therapist accredited
or accreditable with the British Association for Beha-
vioural and Cognitive Psychotherapies. All sessions will
be audio taped. The therapist will keep a diary account
of his/her interventions. Random samples of 1 in 10
therapy sessions (CBT) will be taken and rated using the
Revised Cognitive Therapy Scale [42] to test its applica-
tion in people with ID. A score of 39 or more will be
taken as indicating adequacy of CBT treatment. Adher-
ence to therapy will be measured using the checklist
that has been devised in the CBT manual developed for
the purpose of the study. The checklist will ensure that
essential ingredients are covered by the therapist and if
not, then the reason shall be recorded.
Treatment receipt is concerned with whether the
treatment given is actually understood by the patient.
In order to evaluate this, accessible materials (home/
worksheets) will be developed as part of the manual.
This process will be led by SM and an Accessible
Information Worker who has been developing accessi-
ble materials for people with a range of intellectual
disabilities for several years. The accessible home/
worksheets will be discussed with a service users’ con-
sultation group with whom we have already established
working relationships as a result of other service
related projects.
Treatment enactment suggests that even if the treat-
ment is delivered and understood, it will not be effective
unless the patients act on this. To determine this aspect
the feasibility of the homework tasks will be checked by
piloting a selection of interventions with service users
and determining whether they can be undertaken and if
not why not. We anticipate that individuals will have
difficulties with motivation or ability to complete their
homework, therefore, have enlisted the assistance of the
study support worker in encouraging them to do so.
Statistical analysis
The data will be managed using SPSS (v 14). The ana-
lyses will focus principally on descriptive data on
recruitment rates, characteristics of participants, attri-
tion from therapy and research and the function of the
study manual. We will describe the techniques
employed and documented by the therapists. The pri-
mary outcomes (mean scores and confidence intervals)
will be compared at baseline, four months and six
months post randomisation for both trial arms. We
shall determine the variance of our outcome measures
and the effect size in this feasibility trial in order to
inform the power calculation for a definitive RCT. We
shall also conduct exploratory analyses of factors pre-
dicting treatment outcome such as receipt of medication
(antidepressant), age, course of illness, treatment prefer-
ence and number of sessions received.
All analyses will be by intention-to-treat. The study
will assess the feasibility of recruitment and attrition
from the intervention; applicability of the manualised
CBT and participants’ and informants’ views of the
treatment. We will collect demographic data on all
those approached; will determine the proportion of peo-
ple suitable and those who engage in the study. We will
calculate the means and standard deviations for the
BDI-Y and the BAI-Y. Although caution is necessary as
the variance of the outcome scores in a feasibility study,
it may not truly reflect this in a future trial. The data
will be explored to identify possible predictors of out-
come and factors related to engagement and or attrition.
A descriptive analysis of total costs and individual
resource use components (e.g. primary care, therapy)
will be conducted.
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Whilst the proposed sample size (n = 30) for this trial
is too small to test for statistically significant differences
in clinical or social outcomes between intervention and
control groups, it will investigate the feasibility of the
intervention and likely effect size and recruitment
potential.
Ethical considerations
This trial has been approved by the Joint UCL/UCLH
Committee on the Ethics of Human Research, Commit-
tee Alpha (reference number: 08AL 332).
Informed consent and information sheets
The information sheets and consent forms were devel-
oped in an accessible (i.e. easy-to-read) format by an
accessible information worker as before. The informa-
tion sheets contained a succinct standard script written
in accessible language to be used as an aid to verbally
inform the participants about the trial before written
informed consent is sought from the individuals who
are willing to enter the study. It is essential when work-
ing with people with intellectual disabilities to ensure
that information is understood by frequently checking
and asking the individuals to repeat the information in
their own words. Information should also be concise to
avoid information overload which can be counterpro-
ductive. The participants also will be given information
sheets to take away and go over with their preferred
carer or support worker in their own time and pace.
Withdrawal from the trial
Participants may voluntarily withdraw from the trial for
any reason. The withdrawal of the patient from the trial
will not affect their access to treatment by the relevant
intellectual disability service.
Confidentiality
Each participant will be assigned a unique trial number
in order to store and identify their trial data. All data
for the duration of the study will be kept in locked cabi-
nets in the researcher’s office and on a password locked
computer. The data protection policy of the University
College Medical School will be observed for this project,
which states a 10 year data storage policy.
Discussion
This will be the first randomised controlled trial to eval-
uate a manualised individual cognitive behavioural ther-
apy in treating common affective disorders in people
with mild intellectual disabilities. Successful completion
of the pilot randomised controlled trial will show it is
feasible to recruit participant with intellectual disabilities
to a RCT and to deliver the treatment. The results from
this study are likely to have considerable policy impact
regarding accessibility of psychological treatments by
people with intellectual disabilities in line with the gov-
ernment’s policy for Improving Access Psychological
Therapies (IAPT). Also, it will add to the evidence base
for interventions in people with intellectual disabilities,
which is currently sparse [43].
Demonstrating clinical and cost effectiveness of modi-
fied CBT along with the identifying the clinically useful
elements of the treatment manual would have significant
benefit in relation to current policies in the UK set out
by the National Institute of Clinical Excellence [44]
which advocates CBT as a preferred and effective form
of treatment for depression and anxiety disorders in the
general population and Valuing People [45] which states
that people with intellectual disabilities should have the
same access to healthcare as people without intellectual
disabilities.
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